soman has been researched along with Nervous System Diseases in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (33.33) | 18.7374 |
1990's | 4 (44.44) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Collombet, JM | 1 |
Ashani, Y; Pistinner, S | 1 |
Holstege, CP; Kirk, M; Sidell, FR | 1 |
Adams, N; Corcoran, K; Kaminskis, A; Maitland, G; von Bredow, J; Wade, J | 1 |
Braitman, DJ; Brennecke, LH; Sparenborg, S | 1 |
Nieminen, SA; Sirkka, U; Ylitalo, P | 1 |
Bucci, TJ; Crowell, JA; Dacre, JC; Parker, RM | 1 |
Crowley, RA; Jaax, NK; Mays, MZ; McDonough, JH; Modrow, HE | 1 |
Benschop, HP; De Bisschop, HC; Johnson, MK; Read, DJ; Willems, JL | 1 |
2 review(s) available for soman and Nervous System Diseases
Article | Year |
---|---|
Nerve agent intoxication: recent neuropathophysiological findings and subsequent impact on medical management prospects.
Topics: Animals; Chemical Warfare Agents; Cholinesterase Inhibitors; Disease Management; Humans; Nerve Regeneration; Nervous System Diseases; Soman | 2011 |
Chemical warfare. Nerve agent poisoning.
Topics: Animals; Chemical Warfare Agents; Cholinesterase Inhibitors; Decontamination; Disaster Planning; Emergency Medical Services; Humans; Nervous System Diseases; Organophosphate Poisoning; Organophosphates; Organothiophosphorus Compounds; Sarin; Soman | 1997 |
7 other study(ies) available for soman and Nervous System Diseases
Article | Year |
---|---|
Estimation of the upper limit of human butyrylcholinesterase dose required for protection against organophosphates toxicity: a mathematically based toxicokinetic model.
Topics: Acetylcholinesterase; Butyrylcholinesterase; Chemical Warfare Agents; Cholinesterase Inhibitors; Cholinesterase Reactivators; Dose-Response Relationship, Drug; Erythrocytes; Esterases; Humans; In Vitro Techniques; Inactivation, Metabolic; Models, Biological; Nervous System Diseases; Neuroprotective Agents; Organophosphorus Compounds; Organothiophosphorus Compounds; Reproducibility of Results; Sarin; Soman | 2004 |
Efficacy evaluation of physostigmine and anticholinergic adjuncts as a pretreatment for nerve agent intoxication.
Topics: Animals; Cholinesterases; Erythrocytes; Female; Lethal Dose 50; Macaca fascicularis; Male; Nervous System Diseases; Parasympatholytics; Physostigmine; Scopolamine; Soman; Trihexyphenidyl | 1991 |
Prevention of soman neurotoxicity by non-opioid antitussives.
Topics: Animals; Anticonvulsants; Antitussive Agents; Cyclopentanes; Dextromethorphan; Guinea Pigs; Male; Necrosis; Nervous System Diseases; Neurons; Soman | 1990 |
Neurobehavioral toxicity with low doses of sarin and soman.
Topics: Animals; Avoidance Learning; Behavior, Animal; Male; Nervous System Diseases; Nociceptors; Organophosphorus Compounds; Postural Balance; Psychomotor Performance; Rats; Rats, Inbred Strains; Reaction Time; Sarin; Soman | 1990 |
Neuropathy target esterase in hens after sarin and soman.
Topics: Animals; Chickens; Dose-Response Relationship, Drug; Esterases; Female; Nervous System Diseases; Organophosphorus Compounds; Sarin; Soman; Tritolyl Phosphates | 1989 |
Atropine and/or diazepam therapy protects against soman-induced neural and cardiac pathology.
Topics: Animals; Atropine; Body Weight; Cholinesterase Inhibitors; Diazepam; Drug Interactions; Heart Diseases; Male; Motor Activity; Nervous System Diseases; Rats; Rats, Inbred Strains; Soman | 1989 |
Can soman cause delayed neuropathy?
Topics: Animals; Chickens; Esterases; Isoflurophate; Nervous System Diseases; Soman; Stereoisomerism | 1985 |